Laurie A. Burlingame, Partner, Goodwin to Speak at The Knowledge Group’s Financing Alternatives for Life Sciences Companies LIVE Webcast

Top Quote The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Laurie A. Burlingame, Partner, Goodwin will speak at its webcast entitled, “Emerging Financing Alternatives for Life Sciences Companies: Opportunities and Pitfalls You Need to Know.” This event is scheduled for Friday, October 4, 2019 at 12:00 pm (ET). End Quote
  • (1888PressRelease) October 01, 2019 - For further details, please visit:

    About Laurie A. Burlingame
    Laurie Burlingame is a partner in the firm’s nationally recognized Life Sciences Practice Group. She represents private and public companies across the spectrum of the life sciences industry, including pharmaceuticals, medical devices, diagnostics and biological materials. Ms. Burlingame also represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments.

    Ms. Burlingame often serves as outside general counsel to her clients, closely advising management teams and boards of directors on a wide variety of matters throughout the company’s life cycle, including formation and founder issues, venture capital financings, public offerings, mergers and acquisitions, licensing transactions, strategic collaborations, commercial transactions, corporate governance and other general corporate matters.

    About Goodwin
    Goodwin is a leading Am Law 50 and Global 50 law firm, with offices across the United States and in Europe and Asia. Excelling at complex transactional work and high-stakes litigation, the firm combines in-depth legal knowledge with practical business experience to help clients maximize opportunities and manage risk. With more than 1,000 lawyers, Goodwin offers innovative counsel and delivers results through a client-centric and collaborative approach. The firm focuses on matters involving financial institutions, intellectual property, private equity, real estate capital markets, securities litigation/white collar defense, and technology/life sciences. Information may be found at Follow us on Twitter ( @ ) goodwinlaw dot

    The emergence of real-world data and new digital technologies is fueling growth in the life sciences sector. This trend is resulting to increased investor interest and record funding. In this regard, life sciences businesses are now turning to alternative financing options to fund their growth. These include royalty financing, initial public offerings (IPOs), and collaborative arrangements.

    However, companies that enter these types of financing must be wary of potential drawbacks and reporting challenges. They must clearly understand and comply with the updated rules related to these alternatives. Counsel to businesses must develop an advanced strategic approach to leverage potentials and avoid legal issues.

    Join a panel of key thought leaders and practitioners assembled by The Knowledge Group as they provide the audience with an in-depth discussion of these financing alternatives for the life sciences industry. Speakers will dig deeper as they analyze critical issues surrounding this topic. They will also offer practical tips and strategies to maximize its potentials in light of the recent regulatory developments.

    About The Knowledge Group
    The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit:

  • FB Icon Twitter Icon In-Icon
Contact Information